HEADER DE NOVO PROTEIN 11-OCT-02 1N0A TITLE TURN STABILITY IN BETA-HAIRPIN PEPTIDES: 3:5 TYPE I G1 BULGE TURNS COMPND MOL_ID: 1; COMPND 2 MOLECULE: BHPW_PDG, BETA-HAIRPIN PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. KEYWDS BETA HAIRPIN, BETA-TURN, BETA-BULGE, DE NOVO PROTEIN EXPDTA SOLUTION NMR NUMMDL 21 AUTHOR T.BLANDL,A.G.COCHRAN,N.J.SKELTON REVDAT 3 23-FEB-22 1N0A 1 REMARK LINK REVDAT 2 24-FEB-09 1N0A 1 VERSN REVDAT 1 21-OCT-03 1N0A 0 JRNL AUTH T.BLANDL,A.G.COCHRAN,N.J.SKELTON JRNL TITL TURN STABILITY IN BETA-HAIRPIN PEPTIDES: INVESTIGATION OF JRNL TITL 2 PEPTIDES CONTAINING 3:5 TYPE I G1 BULGE TURNS JRNL REF PROTEIN SCI. V. 12 237 2003 JRNL REFN ISSN 0961-8368 JRNL PMID 12538887 JRNL DOI 10.1110/PS.0228603 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DGII 98.0, DISCOVER 3.0 REMARK 3 AUTHORS : TIM HAVEL (DGII), ACCELRYS (DISCOVER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 100 DISTANCE GEOMETRY STRUCTURES WERE CALCULATED. THE 80 REMARK 3 STRUCTURES OF LOWEST PENALTY FUNCTION WERE FURTHER REFINED USING REMARK 3 RESTRAINED MOLECULAR DYNAMICS. REMARK 3 THE 20 STRUCTURES OF LOWEST RESTRAINT VIOLATION ENERGY WERE USED REMARK 3 TO DESCRIBE THE STRUCTURE. REMARK 3 61 DISTANCE AND 21 DIHEDRAL ANGLE RESTRAINTS WERE USED. REMARK 3 THE FINAL ENSEMBLE HAS NO DISTANCE VIOLATIONS GREATER THAN 0.1 A REMARK 3 AND NO DIHEDRAL ANGLE VIOALTIONS GREATER THAN 1 DEGREE. REMARK 3 95% OF THE RESIDUES ARE IN THE MOST FAVOURABLE REGION OF THE REMARK 3 RAMACHANDRAN PLOT. REMARK 3 THE MEAN BACKBONE ATOM RMSD TO THE MEAN STRUCTURE IS 0.29+/-0.05 A. REMARK 4 REMARK 4 1N0A COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1000017358. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303; 303 REMARK 210 PH : 5.0; 5.0 REMARK 210 IONIC STRENGTH : 0; 0 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 8 MM PEPTIDE, NO BUFFER; 8 MM REMARK 210 PEPTIDE, NO BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D ROESY; 2D TOCSY; DQF-COSY; 2D REMARK 210 COSY-35; 2D 13C-HMQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 2001, FELIX 98.0, REMARK 210 XWINNMR 3.1 REMARK 210 METHOD USED : DISTANCE GEOMETRY AND RESTRAINED REMARK 210 MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 80 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 3 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES AUGMENTED BY LOOSE PHI AND PSI RESTRAINTS REMARK 210 GENERATED FROM TALOS. MODEL 21 IS THE AVERAGE MINIMIZED REMARK 210 STRUCTURE. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 12 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1N09 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS NO SEQUENCE DATABASE REFERENCE SINCE REMARK 999 THE PEPTIDE IS A DE NOVO DESIGNED SEQUENCE. DBREF 1N0A A 0 12 PDB 1N0A 1N0A 0 12 SEQRES 1 A 13 ACE CYS THR TRP GLU PRO ASP GLY LYS LEU THR CYS NH2 HET ACE A 0 6 HET NH2 A 12 3 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N SHEET 1 A 2 THR A 2 TRP A 3 0 SHEET 2 A 2 LEU A 9 THR A 10 -1 O THR A 10 N THR A 2 SSBOND 1 CYS A 1 CYS A 11 1555 1555 2.05 LINK C ACE A 0 N CYS A 1 1555 1555 1.34 LINK C CYS A 11 N NH2 A 12 1555 1555 1.34 SITE 1 AC2 1 CYS A 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C ACE A 0 10.089 1.340 -9.972 1.00 0.00 C HETATM 2 O ACE A 0 9.977 0.225 -9.462 1.00 0.00 O HETATM 3 CH3 ACE A 0 11.390 1.739 -10.658 1.00 0.00 C HETATM 4 H1 ACE A 0 12.106 0.919 -10.604 1.00 0.00 H HETATM 5 H2 ACE A 0 11.195 1.975 -11.704 1.00 0.00 H HETATM 6 H3 ACE A 0 11.811 2.614 -10.162 1.00 0.00 H